Search global stocks & ETFs...Ctrl K
Learn Mode
MRK
Stock Profile
08-04
Recommended Metric
Score Card
Explore Scores Tab
3.38
Average
Valuation Score
Key Score
3.00
Average
Management
1.00
Very Bad
Growth
5.00
Very Good
Profitability
5.00
Very Good
Fin. Health
3.00
Average
Dividends
2.00
Bad
Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$115.44
Baseline
High
$157.50
▲
36.43%
Avg
$131.75
▲
14.13%
Low
$101.00
▼
-12.51%
Analyst Ratings based on 36 Analysts
Strong Buy
925%
Buy
1644%
Hold
1131%
Sell
000%
Strong Sell
000%
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.Read More
Stock News
View All Updates
News100%Bullish
Merck (MRK) Taps Protillion For AI Drug Discovery And Expands HPV Outreach
14hYahoo
Explore the top gainers and losers within the dow jones index in today's session.
14hChartMill
Eli Lilly Stock's Trillion-Dollar Question
15hYahoo
Here’s Why Merck (MRK) is Among the 10 Undervalued Counter Cyclical Stocks to Buy Now
16hYahoo
Gilead Sciences (GILD) Donates Remdesivir to Uganda
16hYahoo
MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts
16hYahoo
The Number That Could Test Johnson & Johnson Stock
16hYahoo
Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished
17hYahoo
Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
21hYahoo
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
22hYahoo
SCHD: Not My Highest Yielder, But It May Be My Most Important ETF
1dSeekingAlpha
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
1dYahoo
How America Got to SpaceX: The Long Trail of Big IPOs That Began in 1783
1dYahoo
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
1dYahoo
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV Prevention
1dYahoo
Jetstream Venture Fund Secures Position in Rejuvenate Bio, Investing Alongside Industry Giant Merck
1dYahoo
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
1dYahoo
Nivi, Inc. and MSD Collaborate to Expand HPV Disease Awareness and Cervical Cancer Prevention Through AI-Powered Platform
1dYahoo
Protillion Biosciences Announces Drug Discovery Collaboration with Merck
1dYahoo
3 Dividend Stocks to Hold for the Long Haul
1dYahoo
Protillion Biosciences Signs Discovery Collaboration, License Deal With Merck To Integrate Its Platform With Merck's Expertise For Novel Therapeutic Candidates Discovery
2dBenzinga
Merck: Buy The Dip On This Dividend Growth Pharma Leader
2dSeekingAlpha
Discover which dow jones stocks are making waves on Monday.
2dChartMill
3 Stocks Estimated To Be Up To 46.2% Below Fair Value Offering A 12.2% Discount Opportunity
2dYahoo
June 2026's Noteworthy Stocks Estimated Below Intrinsic Value
2dYahoo
Immuneering Appoints Andrew Gengos as Chief Financial Officer
2dYahoo
Jim Cramer Explains Johnson & Johnson’s (JNJ) Shares Have Gained
3dYahoo
What Could Push JNJ Stock Higher From Here?
5dYahoo
Merck (MRK) Stock After 53% One-Year Gain Is DCF Signaling Further Upside Potential
5dYahoo
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
5dYahoo
Sector Update: Healthcare Stocks Softer Late Afternoon
5dYahoo
JNJ Raised the Bar: So Why Is the Stock Standing Still?
5dYahoo
Stay informed with the top movers within the dow jones index on Friday.
5dChartMill
The Catch Hiding In Eli Lilly Stock's Growth Story
5dYahoo
Can Bristol Myers' Growth Portfolio Offset Legacy Drug Declines?
5dYahoo
Top dow jones movers in Friday's session
5dChartMill
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
5dYahoo
Merck's Belzutifan In Combination With Pembrolizumab Receives FDA Approval To Treat Adults With Renal Cell Carcinoma
5dBenzinga
PAHC Stock: What's Driving Phibro's Animal Health Growth
5dYahoo
Alpha Tau Medical: A Lot Of Shots On Goal
6dSeekingAlpha
Merck TARGAN Deal Highlights Poultry Tech Push And Undervalued Share Price
6dYahoo
Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
6dYahoo
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now?
6dYahoo
Why Did Wall Street Misprice JNJ Stock?
6dYahoo
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
6dYahoo
Discover which dow jones stocks are making waves on Thursday.
6dChartMill
The Zacks Analyst Blog Highlights Merck, The Southern, Lumentum and Peoples Bancorp of North Carolina
6dYahoo
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
6dYahoo
Is PAHC Undervalued at 10x Earnings vs Peers?
6dYahoo
Merck Animal Health to Acquire TARGAN
6dYahoo